CYP7B1 and metabolic dysfunction-associated steatohepatitis: The expression of CYP7B1 has been found elevated in NASH patients, while CYP8B1 was down-regulated, suggesting a possible shift towards the alternative pathway of bile acid synthesis during disease progression [84].